CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 74 filers reported holding CYTOSORBENTS CORP in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $25,000 | -86.1% | 11,464 | -79.7% | 0.00% | -81.2% |
| Q1 2022 | $180,000 | +130.8% | 56,554 | +202.9% | 0.02% | +100.0% |
| Q4 2021 | $78,000 | -92.1% | 18,671 | -84.6% | 0.01% | -91.6% |
| Q3 2021 | $982,000 | +9.1% | 120,879 | +1.4% | 0.10% | +11.8% |
| Q2 2021 | $900,000 | -13.8% | 119,181 | -0.9% | 0.08% | -27.4% |
| Q1 2021 | $1,044,000 | +37.2% | 120,295 | +26.0% | 0.12% | +39.3% |
| Q4 2020 | $761,000 | +56.3% | 95,448 | +56.4% | 0.08% | +20.0% |
| Q3 2020 | $487,000 | +170.6% | 61,013 | +235.0% | 0.07% | +250.0% |
| Q2 2020 | $180,000 | +133.8% | 18,215 | +81.9% | 0.02% | +81.8% |
| Q1 2020 | $77,000 | +14.9% | 10,016 | -42.3% | 0.01% | +175.0% |
| Q4 2019 | $67,000 | -81.2% | 17,364 | -75.5% | 0.00% | -77.8% |
| Q3 2019 | $356,000 | – | 70,843 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 450,000 | $1,616 | 1.58% |
| Skylands Capital, LLC | 2,793,470 | $10,028,557 | 1.44% |
| Sargent Investment Group, LLC | 1,289,546 | $4,629,470 | 1.12% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 237,940 | $854,205 | 0.96% |
| Avenir Corp | 2,719,732 | $9,763,838 | 0.86% |
| Granahan Investment Management | 1,616,587 | $5,803,547 | 0.18% |
| Seelaus Asset Management LLC | 20,450 | $73 | 0.06% |
| Cowen Prime Advisors LLC | 42,301 | $151,861 | 0.05% |
| HighMark Wealth Management LLC | 10,000 | $35,900 | 0.03% |
| Key Client Fiduciary Advisors, LLC | 12,000 | $43,080 | 0.02% |